News

The iconic romance film twirled its way into hearts in 1987, pairing together an unlikely but enduring on-screen couple ...
The FDA’s De Novo authorization for the tool establishes a new product code category for future AI-powered digital pathology risk-stratification tools.
In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line setting for metastatic castration-resistant prostate cancer.
The Food and Drug Administration has granted Fast Track designation to HLD-0915 for the treatment of patients with metastatic castration-resistant prostate cancer.
A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates compared to ...
Public awareness about the link between human papillomavirus, or HPV, and cancer is low. A doctor explains why its lifesaving properties matter.
OXNARD, Calif. — Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time.
Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time.
Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time.
Cowboys owner Jerry Jones reveals his cancer diagnosis in a new Cowboys documentary series on Netflix.